Partnering with Peers and Patients: Achieving T2DM Treatment Goals with GLP-1 RA Therapy
1.25 hr(s) | CME
Therapeutic Area(s): Endocrinology
Release Date: March 31, 2021
Expiration Date: March 30, 2022
Location: Internet Activity Enduring
In this activity, an expert in type 2 diabetes (T2DM) management discusses how to individualize treatment with GLP-1 RAs to improve outcomes for patients.